13th International Conference of the Society of Integrative Oncology

Integrative Oncology

Jo Cavallo  / December 25, 2016  / 13th International Conference of the Society of Integrative Oncology

The Best of SIO

The following five abstracts were chosen as the best submitted studies presented at this year’s International Conference of the Society for Integrative Oncology (SIO). They represent a diverse group o...

Integrative Oncology

Jo Cavallo  / December 25, 2016  / 13th International Conference of the Society of Integrative Oncology

Advancing the Global Impact of Integrative Oncology

The 13th International Conference of the Society of Integrative Oncology (SIO) held in Miami, Florida, in November, drew its largest audience yet, with nearly 400 clinicians, researchers, patients, a...

Advertisement

Advertisement



Jun
20
Today In Oncology
EHA 2018: Elotuzumab Plus Pomalidomide and Low-Dose Dexamethasone vs Pomalidomide/Dexamethasone Alone in Relapsed or Refractory Multiple Myeloma
EHA 2018: Obinutuzumab or Rituximab Plus Chlorambucil in CLL
EHA 2018: Alvocidib in Patients With Relapsed or Refractory MCL-1–Dependent AML
Final Overall Survival Analysis of First-Line Crizotinib vs Chemotherapy in Advanced ALK-Positive NSCLC
EHA 2018: Tisagenlecleucel Demonstrates More Than 1-Year Durability of Response in Adults With Relapsed or Refractory DLBCL
View More 
;
Advertisement
Most Read Stories
FDA Approves Pembrolizumab for Previously Treated Recurrent or Metastatic PD-L1–Expressing Cervical Cancer
Is CAR T-Cell Therapy Setting a New Standard of Care in Lymphoma?
2018 ASCO: Adjuvant mFOLFIRINOX vs Gemcitabine in Resected Pancreatic Cancer
PD-L1 Inhibitor Consolidation Therapy for NSCLC: New Standard of Care?
Rivaroxaban vs Dalteparin in Patients With Venous Thromboembolism
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.